Reviewed by Jonathan Teplitsky · Updated September 2026 · Informational only — not legal or medical advice; Rank and Pay is not affiliated with the VA.

The Department of Veterans Affairs (VA) evaluates active bladder cancer at a temporary 100 percent disability rating under Diagnostic Code 7528, then reassesses the veteran six months after treatment ends to assign a permanent rating based on voiding or renal dysfunction. Service connection is established on a presumptive basis for veterans with qualifying exposure to tactical herbicides or specific environmental toxins. When active therapy concludes, the rating does not drop to zero; instead, VA rebuilds the evaluation around the functional residuals left by the disease and surgical interventions. Claimants who experience multiple service-connected disabilities alongside bladder conditions can model their combined percentages through the VA disability rating calculator.

Agent Orange Presumptive Status for Bladder Cancer

Bladder cancer is an Agent Orange presumptive condition codified at 38 CFR § 3.309(e) following regulatory action that took effect on January 1, 2021. The Department of Veterans Affairs added the disease after the National Academy of Sciences released its 11th biennial update report on Vietnam veterans and herbicide exposure, which reviewed cumulative health data alongside updates for hypothyroidism and Parkinsonism.

Presumptive service connection removes the requirement to submit an independent medical nexus linking the diagnosis to military chemical contact. A claimant only needs to present service records demonstrating duty in a designated presumptive location and official medical documentation confirming a primary bladder cancer diagnosis. Sibling guidelines detailing other expansions are outlined in the Agent Orange additions guide and the general Agent Orange exposure overview.

Qualifying military service for the Agent Orange presumption includes:

Rating Active Bladder Cancer Under Diagnostic Code 7528

The VA rates active bladder cancer under Diagnostic Code 7528 in 38 CFR § 4.115b at a temporary 100 percent evaluation. Diagnostic Code 7528 applies to all malignant neoplasms of the genitourinary system. This rating covers the active presence of cancer and all continuous antineoplastic treatment, including surgical excision, intravesical therapy, radiation, and systemic chemotherapy.

The 100 percent evaluation remains in effect during active treatment and continues until a mandatory medical examination scheduled six months after the completion of antineoplastic therapy. This delayed review mirrors the schedule used for other service-connected malignancies, such as the skin cancer standards described on the melanoma VA rating page. The VA schedules this examination to determine whether the cancer has cleared or remains present.

If the medical examination demonstrates that the cancer is active, has spread, or has recurred, the 100 percent rating continues. If clinical evidence confirms the malignancy is in remission, the adjudicator terminates the temporary 100 percent evaluation and assigns a rating based on the residual functional damage left behind.

Post-Treatment Residual Ratings Under 38 CFR 4.115a

Following the mandatory six-month post-treatment examination, VA rates bladder cancer residuals under 38 CFR § 4.115a according to whichever dysfunction yields the higher evaluation. Adjudicators evaluate the veteran under either voiding dysfunction or renal dysfunction. The rating schedule dictates that the veteran receives whichever evaluation provides the higher percentage, rather than combining separate ratings for the same anatomical defect.

Voiding Dysfunction Ratings for Urine Leakage

Continual urine leakage from bladder cancer residuals is rated under voiding dysfunction based on the daily frequency of absorbent pad changes. Surgical resections, nerve damage, or radical cystectomies often leave veterans with ongoing incontinence that requires mechanical appliances or absorbent briefs.

Medical documentation must specify the precise daily frequency of pad changes. A physician note that simply states the veteran wears protective pads is insufficient for the higher rating brackets; the record must explicitly document the number of times materials are replaced each day.

Voiding Dysfunction Ratings for Urinary Frequency

Urinary frequency following bladder cancer treatment is evaluated under voiding dysfunction by measuring daytime voiding intervals and nocturnal awakening. Scarring of the bladder wall or reduced bladder capacity frequently results in shortened intervals between urination.

When a veteran exhibits both leakage and urinary frequency, the VA evaluates both symptoms under the voiding dysfunction table and assigns the single highest percentage applicable to the condition.

Renal Dysfunction Ratings for Kidney Impairment

Renal dysfunction is rated under 38 CFR 4.115a when bladder cancer surgery or urinary obstruction impairs kidney clearance. Damage from retroperitoneal surgery, ureteral reimplantation, or chronic urinary retention can cause kidney dysfunction measured by laboratory filtration panels.

Adjudicators cross-check nephrology reports, creatinine blood panels, and glomerular filtration numbers to confirm whether kidney impairment produces a higher evaluation than voiding dysfunction.

Due Process Protections and the 38 CFR 3.105e Procedure

The VA must follow strict due process procedures under 38 CFR § 3.105(e) before reducing a temporary 100 percent cancer rating. A regional office cannot abruptly lower a veteran's compensation when treatment stops. The reduction process requires clear sequence steps to allow the veteran an opportunity to respond.

Once the mandatory six-month post-treatment Compensation and Pension (C&P) examination demonstrates disease remission, the VA issues a formal notice of proposed reduction. This document outlines the proposed lower rating based on residual symptoms. The veteran receives 60 days from the notice date to present additional medical evidence and 30 days to request a personal hearing. Monthly disability payments continue at the 100 percent level throughout this statutory response window.

Earlier Effective Dates and the Nehmer Consent Decree

Veterans previously denied service connection for bladder cancer before January 1, 2021, may qualify for retroactive compensation under the Nehmer class action decree. The landmark consent decree in Nehmer v. United States Department of Veterans Affairs protects covered Vietnam veterans when a condition is newly added to the Agent Orange presumptive schedule.

Under the Nehmer rules, if a qualifying veteran filed a claim for bladder cancer that the VA previously denied before the 2021 presumptive addition, the agency must review the earlier claim. In certain cases, this review permits an effective date reaching back to the date of the earlier denial. The application of these rules depends on specific service records, claim timelines, and prior rating notices. Claimants can read about prior claim adjustments on the VA disability back pay guide and review specific claim histories with an accredited representative.

Evidence Requirements for a Bladder Cancer VA Rating

Filing a successful bladder cancer claim requires service personnel records, a definitive medical diagnosis, and contemporaneous documentation of treatment or ongoing residuals. A DD-214 must show boots-on-the-ground service in Vietnam, territorial offshore waters, the Korean DMZ, or one of the presumptive perimeters established by the PACT Act. Pathology reports from a biopsy or surgical specimen are required to confirm the presence of primary malignant neoplasms.

Claimants who are currently receiving treatment should submit surgical records, oncology treatment plans, chemotherapy notes, and radiation documentation to secure the temporary 100 percent rating under Diagnostic Code 7528. Veterans entering remission should maintain daily voiding logs, track pad usage, and request lab reports from their urologist to establish their residual evaluation under 38 CFR 4.115a. Veterans who served in locations outside presumptive zones may need to consult the nexus letter guide for medical nexus requirements. Review your military service records to confirm qualifying exposure dates, request your complete oncology treatment files, and submit VA Form 21-526EZ to establish your bladder cancer va rating.

This page is informational only and is not legal or medical advice. Rank and Pay is not affiliated with the Department of Veterans Affairs. Rating criteria are summarized from 38 CFR Part 4; for your specific claim, consult the VA, an accredited Veterans Service Officer (VSO), or an accredited attorney.